FDA Approves Stent to Treat Coronary Bifurcation Lesions Involving Large Side Branches
from Cardiovascular Business
The Food and Drug Administration approved the Tryton Side Branch Stent March 6 to treat coronary bifurcation lesions involving large side branches that are appropriate for a 2.5 mm or larger stent. Tryton Medical, which manufactures the stent, announced the approval in a news release.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063